Genetic
and
non-genetic
factors
are
responsible
for
the
high
interindividual
variability
in
response
to
SARS-CoV-2.
Although
numerous
genetic
polymorphisms
have
been
identified
as
risk
severe
COVID-19,
these
remain
understudied
Latin-American
populations.
This
study
evaluated
association
of
three
polymorphisms:
Biomedicine & Pharmacotherapy,
Год журнала:
2022,
Номер
157, С. 113977 - 113977
Опубликована: Ноя. 7, 2022
COVID-19
is
a
worldwide
pandemic
caused
by
SARS-coronavirus-2
(SARS-CoV-2).
Less
than
year
after
the
emergence
of
Covid-19
pandemic,
many
vaccines
have
arrived
on
market
with
innovative
technologies
in
field
vaccinology.
Based
use
messenger
RNA
(mRNA)
encoding
Spike
SARS-Cov-2
protein
or
recombinant
adenovirus
vectors
enabling
gene
to
be
introduced
into
our
cells,
these
strategies
make
it
possible
envisage
vaccination
new
light
tools
that
are
more
scalable
vaccine
used
so
far.
Faced
appearance
variants,
which
will
gradually
take
precedence
over
strain
at
origin
allow
much
faster
update
fight
against
some
may
escape
neutralization
antibodies.
However,
only
policy
based
rapid
and
massive
population
but
requiring
supply
sufficient
doses
could
combat
variants.
Indeed,
greater
number
infected
individuals,
virus
multiplies,
an
increased
risk
variants
viruses.
This
review
discuss
SARS-CoV-2
pathophysiology
evolution
approaches
altered
transmission
platforms
emphasize
different
mutations
how
they
influence
characteristics.
Also,
this
article
summarizes
common
implication
genetic
variety
biomedical
arbitrations.
Human Molecular Genetics,
Год журнала:
2022,
Номер
31(23), С. 3945 - 3966
Опубликована: Июль 15, 2022
Abstract
Given
the
highly
variable
clinical
phenotype
of
Coronavirus
disease
2019
(COVID-19),
a
deeper
analysis
host
genetic
contribution
to
severe
COVID-19
is
important
improve
our
understanding
underlying
mechanisms.
Here,
we
describe
an
extended
genome-wide
association
meta-analysis
well-characterized
cohort
3255
patients
with
respiratory
failure
and
12
488
population
controls
from
Italy,
Spain,
Norway
Germany/Austria,
including
stratified
analyses
based
on
age,
sex
severity,
as
well
targeted
chromosome
Y
haplotypes,
human
leukocyte
antigen
region
SARS-CoV-2
peptidome.
By
inversion
imputation,
traced
reported
at
17q21.31
~0.9-Mb
polymorphism
that
creates
two
differentiated
haplotypes
characterized
potential
effects
in
detail.
Our
data,
together
5th
release
summary
statistics
Host
Genetics
Initiative
non-Caucasian
individuals,
also
identified
new
locus
19q13.33,
NAPSA,
gene
which
expressed
primarily
alveolar
cells
responsible
for
gas
exchange
lung.
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Июнь 13, 2023
Abstract
Some
people
remain
healthier
throughout
life
than
others
but
the
underlying
reasons
are
poorly
understood.
Here
we
hypothesize
this
advantage
is
attributable
in
part
to
optimal
immune
resilience
(IR),
defined
as
capacity
preserve
and/or
rapidly
restore
functions
that
promote
disease
resistance
(immunocompetence)
and
control
inflammation
infectious
diseases
well
other
causes
of
inflammatory
stress.
We
gauge
IR
levels
with
two
distinct
peripheral
blood
metrics
quantify
balance
between
(i)
CD8
+
CD4
T-cell
(ii)
gene
expression
signatures
tracking
longevity-associated
immunocompetence
mortality-associated
inflammation.
Profiles
~48,500
individuals
collectively
indicate
some
persons
resist
degradation
both
during
aging
when
challenged
varied
stressors.
With
resistance,
preservation
tracked
a
lower
risk
HIV
acquisition,
AIDS
development,
symptomatic
influenza
infection,
recurrent
skin
cancer;
survival
COVID-19
sepsis;
(iii)
longevity.
potentially
reversible
by
decreasing
Overall,
show
trait
observed
across
age
spectrum,
more
common
females,
aligned
specific
immunocompetence-inflammation
linked
favorable
immunity-dependent
health
outcomes.
mechanisms
have
utility
biomarkers
for
measuring
improving
Viruses,
Год журнала:
2022,
Номер
14(6), С. 1297 - 1297
Опубликована: Июнь 14, 2022
This
retrospective
multi-center
matched
cohort
study
assessed
the
risk
for
severe
COVID-19
(combination
of
severity
indicators),
intensive
care
unit
(ICU)
admission,
and
in-hospital
mortality
in
hospitalized
patients
when
infected
with
Omicron
variant
compared
to
Delta
variant.
The
is
based
on
a
causal
framework
using
individually-linked
data
from
national
registries.
population
consisted
954
(of
which,
445
were
Omicron)
above
18
years
old
admitted
Belgian
hospital
during
autumn
winter
season
2021–2022,
available
viral
genomic
data.
Patients
hospital,
whereas
other
possible
confounders
(demographics,
comorbidities,
vaccination
status,
socio-economic
ICU
occupancy)
adjusted
by
multivariable
logistic
regression
analysis.
estimated
standardized
admission
was
significantly
lower
(RR
=
0.63;
95%
CI
(0.30;
0.97)
RR
0.56;
(0.14;
0.99),
respectively)
variant,
not
different
according
SARS-CoV-2
0.78,
(0.28–1.29)).
demonstrates
added
value
integrated
clinical
surveillance
recognize
multifactorial
nature
pathogenesis.
Translational Neurodegeneration,
Год журнала:
2022,
Номер
11(1)
Опубликована: Сен. 11, 2022
Coronavirus
disease
2019
(COVID-19),
which
is
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
a
life-threatening
disease,
especially
in
elderly
individuals
and
those
with
comorbidities.
The
predominant
clinical
manifestation
of
COVID-19
dysfunction,
while
neurological
presentations
are
increasingly
being
recognized.
SARS-CoV-2
invades
host
cells
primarily
via
attachment
the
spike
protein
to
angiotensin-converting
enzyme
(ACE2)
receptor
expressed
on
cell
membranes.
Patients
Alzheimer's
(AD)
more
susceptible
infection
prone
outcomes.
Recent
studies
have
revealed
some
common
risk
factors
for
AD
COVID-19.
An
understanding
association
between
potential
related
mechanisms
may
lead
development
novel
approaches
treating
both
diseases.
In
present
review,
we
first
summarize
central
nervous
system
(CNS)
then
discuss
associations
shared
key
AD,
focus
ACE2
receptor,
apolipoprotein
E
(APOE)
genotype,
age,
neuroinflammation.
Proceedings of the National Academy of Sciences,
Год журнала:
2022,
Номер
119(21)
Опубликована: Май 20, 2022
Significance
Middle
East
respiratory
syndrome
coronavirus
(MERS-CoV)
causes
highly
lethal
disease.
MERS-CoV
encodes
innate
immune
antagonists,
including
accessory
proteins
NS4a
and
NS4b,
unique
to
the
merbeco
lineage
of
betacoronaviruses,
nsp15
protein
endoribonuclease
(EndoU),
conserved
among
all
coronaviruses.
While
mutation
each
antagonist
alone
has
little
effect
on
immunity,
infections
with
recombinant
MERS-CoVs
mutations
EndoU
in
combination
either
or
NS4b
activate
signaling
pathways
are
attenuated
for
replication.
Our
data
indicate
that
together
suppress
immunity
during
infection,
optimize
viral
This
is
contrast
SARS-CoV-2
which
activates
these
thus
more
vulnerable
host
responses.
PLoS ONE,
Год журнала:
2023,
Номер
18(2), С. e0281750 - e0281750
Опубликована: Фев. 16, 2023
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2)
has
been
responsible
for
the
recent
pandemic
since
early
2020.
Due
to
wide
range
of
clinical
symptoms
this
disease,
from
asymptomatic
severe
and
critical
forms,
it
seems
that
genetic
differences
among
patients,
along
with
other
factors
(such
as
gender,
age,
underlying
diseases),
can
explain
part
variation
in
disease
symptoms.
The
TMPRSS2
enzyme
plays
a
vital
role
stages
interaction
SARS-CoV-2
host
cells
by
facilitating
viral
entry.
There
is
polymorphism
gene,
called
rs12329760(C
T)
missense
variant,
which
causes
replacement
valine
methionine
protein
at
position
160.
present
study
investigated
association
between
genotype
severity
2019
(COVID-19)
Iranian
patients.
251
COVID-19
patients
(151
mild
100
symptoms)
was
detected
on
genomic
DNA
extracted
patients’
peripheral
blood
via
ARMS-PCR
method.
Our
results
showed
significant
minor
T
allele
(
P-value
=
0.043)
under
dominant
additive
inheritance
model.
In
conclusion,
rs12329760
gene
risk
form
contrast
most
previous
studies
variant
European
ancestry
populations
suggested
protective
allele.
reiterate
ethnic-specific
alleles
hidden
unknown
complexity
behind
susceptibility.
However,
further
are
needed
address
complex
mechanisms
determining
severity.
Abstract
Three
and
a
half
years
after
the
pandemic
outbreak,
now
that
WHO
has
formally
declared
emergency
is
over,
COVID-19
still
significant
global
issue.
Here,
we
focus
on
recent
developments
in
genetic
genomic
research
COVID-19,
give
an
outlook
state-of-the-art
therapeutical
approaches,
as
gradually
transitioning
to
endemic
situation.
The
sequencing
characterization
of
rare
alleles
different
populations
made
it
possible
identify
numerous
genes
affect
either
susceptibility
or
severity
disease.
These
findings
provide
beginning
new
avenues
pan-ethnic
therapeutic
well
potential
screening
protocols.
causative
virus,
SARS-CoV-2,
spotlight,
but
novel
threatening
virus
could
appear
anywhere
at
any
time.
Therefore,
continued
vigilance
further
warranted.
We
also
note
emphatically
prevent
future
pandemics
other
world-wide
health
crises,
imperative
capitalize
what
have
learnt
from
COVID-19:
specifically,
regarding
its
origins,
world’s
response,
insufficient
preparedness.
This
requires
unprecedented
international
collaboration
timely
data
sharing
for
coordination
effective
response
rapid
implementation
containment
measures.